In controlled clinical studies as both monotherapy and combination therapy with metformin, pioglitazone, or rosiglitazone and metformin, the overall incidence of adverse reactions, hypoglycemia, and discontinuation of therapy due to clinical adverse reactions with JANUVIA were similar to placebo
In a phase 2 study, AR inhibitor enzalutamide demonstrated clinical activity and was well tolerated in patients with advanced AR-positive TNBC
GLP-1 medications work by helping the body regulate appetite and metabolism, leading to steady, sustainable fat reduction
Persistent vomiting or diarrhoea can lead to dehydration and potential kidney problems, which is particularly concerning for people with diabetes, and may necessitate temporary adjustment of your diabetes medications
The final screen tells patients A provider will soon be reaching out to you through your secure chat to confirm your prescription and notes that in most states a video call is not required